Skip to main content
SpringerLink
Log in

Advisable Follow-Up for Kidney Tumors

  • Reference work entry
  • First Online:
Urologic Oncology

  • 719 Accesses

Abstract

Currently, no consensus has been reached regarding follow-up strategies after treatment of nonmetastatic renal cell carcinoma (RCC). Apart from functional control and a psychosocial need to follow patients after the diagnosis and treatment of cancer with curative intent, evidence is lacking whether follow-up changes the natural history of RCC after local treatment. Nevertheless, most guidelines recommend follow-up, and retrospective data suggest that risk of recurrence, type of treatment, and competing risks such as comorbidity and age can be used to individualize follow-up in patients with RCC.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 599.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 899.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abdollah F, Suardi N, Capitanio U, Matloob R, Fossati N, Castiglione F, et al. The key role of time in predicting progression-free survival in patients with renal cell carcinoma treated with partial or radical nephrectomy: conditional survival analysis. Urol Oncol. 2014;32(1):43.e9–16.

    Article  Google Scholar 

  • Akatsu T, Shimazu M, Aiura K, Ito Y, Shinoda M, Kawachi S, et al. Clinicopathological features and surgical outcome of isolated metastasis of renal cell carcinoma. Hepato-Gastroenterology. 2007;54(78):1836–40.

    PubMed  Google Scholar 

  • Alt AL, Boorjian SA, Lohse CM, Costello BA, Leibovich BC, Blute ML. Survival after complete surgical resection of multiple metastases from renal cell carcinoma. Cancer. 2011;117:2873–82.

    Article  Google Scholar 

  • Bani-Hani AH, Leibovich BC, Lohse CM, Cheville JC, Zincke H, Blute ML. Associations with contralateral recurrence following nephrectomy for renal cell carcinoma using a cohort of 2,352 patients. J Urol. 2005;173(2):391–4.

    Article  Google Scholar 

  • Bianchi M, Sun M, Jeldres C, Shariat SF, Trinh QD, Briganti A, et al. Distribution of metastatic sites in renal cell carcinoma: a population-based analysis. Ann Oncol. 2012;23(4):973–80.

    Article  CAS  Google Scholar 

  • Bianchi M, Becker A, Hansen J, Trinh QD, Tian Z, Abdollah F, et al. Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time. BJU Int. 2013;111(8):E283–9.

    Article  Google Scholar 

  • Borghesi M, Brunocilla E, Schiavina R, Martorana G. Positive surgical margins after nephron-sparing surgery for renal cell carcinoma: incidence, clinical impact, and management. Clin Genitourin Cancer. 2013;11(1):5–9.

    Article  Google Scholar 

  • Bruno JJ, Snyder ME, Motzer RJ, Russo P. Renal cell carcinoma local recurrences: impact of surgical treatment and concomitant metastasis on survival. BJU Int. 2006;97(5):933–8.

    Article  Google Scholar 

  • Capogrosso P, Capitanio U, La Croce G, Nini A, Salonia A, Montorsi F, Bertini R. Follow-up after treatment for renal cell carcinoma: the evidence beyond the guidelines. EU Focus. 2015;(in press).

    Google Scholar 

  • Dabestani S, Marconi L, Hofmann F, Stewart F, Lam TBL, Canfield SE, Staehler M, Powles T, Ljungberg B, Bex A. Local treatments for metastases of renal-cell carcinoma: a systematic review. Lancet Oncol. 2014;15(12):e549–61.

    Article  Google Scholar 

  • Dabestani S, Thorstenson A, Lindblad P, Harmenberg U, Ljungberg B, Lundstam S. Renal cell carcinoma recurrences and metastases in primary non-metastatic patients: a population-based study. World J Urol. 2016;34:1081–6.

    Article  Google Scholar 

  • Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg. 2004;240(2):205–13.

    Article  Google Scholar 

  • Klatte T, Remzi M, Zigeuner RE, Mannweiler S, Said JW, Kabbinavar FF, et al. Development and external validation of a nomogram predicting disease specific survival after nephrectomy for papillary renal cell carcinoma. J Urol. 2010;184(1):53–8.

    Article  Google Scholar 

  • Kreshover JE, Richstone L, Kavoussi LR. Renal cell recurrence for T1 tumors after laparoscopic partial nephrectomy. J Endourol. 2013;27(12):1468–70.

    Article  Google Scholar 

  • Kuijpers YA, Meijer RP, Jonges GN, de Jong J, Bosch JL, Horenblas S, et al. Potentially curable recurrent disease after surgically managed non-metastatic renal cell carcinoma in low-, intermediate- and high-risk patients. World J Urol. 2016;34:1073–9.

    Article  CAS  Google Scholar 

  • Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, et al. Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials. Cancer. 2003;97(7):1663–71.

    Article  Google Scholar 

  • Li P, Znaor A, Holcatova I, Fabianova E, Mates D, Wozniak MB, et al. Regional geographic variations in kidney cancer incidence rates in European countries. Eur Urol. 2015;67(6):1134–41.

    Article  Google Scholar 

  • Ljungberg B, Bensalah K, Canfield S, Dabestani S, Hofmann F, Hora M, et al. EAU guidelines on renal cell carcinoma: 2014 update. Eur Urol. 2015;67(5):913–24.

    Article  Google Scholar 

  • Marszalek M, Carini M, Chlosta P, Jeschke K, Kirkali Z, Knuchel R, et al. Positive surgical margins after nephron-sparing surgery. Eur Urol. 2012;61(4):757–63.

    Article  Google Scholar 

  • Oddsson SJ, Hardarson S, Petursdottir V, Jonsson E, Sigurdsson MI, Einarsson GV, et al. Synchronous pulmonary metastases from renal cell carcinoma – a whole nation study on prevalence and potential resectability. Scand J Surg. 2012;101(3):160–5.

    Article  CAS  Google Scholar 

  • Patard JJ, Kim HL, Lam JS, Dorey FJ, Pantuck AJ, Zisman A, et al. Use of the University of California Los Angeles integrated staging system to predict survival in renal cell carcinoma: an international multicenter study. J Clin Oncol. 2004;22(16):3316–22.

    Article  Google Scholar 

  • Psutka SP, Heidenreich M, Boorjian SA, Bailey GC, Cheville JC, Stewart-Merrill SB, et al. Renal fossa recurrence after nephrectomy for renal cell carcinoma: prognostic features and oncological outcomes. BJU Int. 2017 Jan;119(1):116–127. https://doi.org/10.1111/bju.13620. Epub 2016 Aug 31.

    Article  Google Scholar 

  • Sandhu SS, Symes A, A'Hern R, Sohaib SA, Eisen T, Gore M, et al. Surgical excision of isolated renal-bed recurrence after radical nephrectomy for renal cell carcinoma. BJU Int. 2005;95(4):522–5.

    Article  Google Scholar 

  • Shindo T, Masumori N, Kobayashi K, Fukuta F, Hirobe M, Tonooka A, et al. Long-term outcome of small, organ-confined renal cell carcinoma (RCC) is not always favourable. BJU Int. 2013;111(6):941–5.

    Article  Google Scholar 

  • Sorbellini M, Kattan MW, Snyder ME, Reuter V, Motzer R, Goetzl M, et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell renal cell carcinoma. J Urol. 2005;173(1):48–51.

    Article  Google Scholar 

  • Sternberg CN, Davis ID, Mardiak J, Szczylik C, Lee E, Wagstaff J, et al. Pazopanib in locally advanced or metastatic renal cell carcinoma: results of a randomized phase III trial. J Clin Oncol. 2010;28(6):1061–8.

    Article  CAS  Google Scholar 

  • Stewart SB, Thompson RH, Psutka SP, Cheville JC, Lohse CM, Boorjian SA, et al. Evaluation of the National Comprehensive Cancer Network and American Urological Association renal cell carcinoma surveillance guidelines. J Clin Oncol. 2014;32(36):4059–65.

    Article  Google Scholar 

  • Stewart-Merrill SB, Thompson RH, Boorjian SA, Psutka SP, Lohse CM, Cheville JC, et al. Oncologic surveillance after surgical resection for renal cell carcinoma: a novel risk-based approach. J Clin Oncol. 2015;33(35):4151–7.

    Article  Google Scholar 

  • Sun M, Shariat SF, Cheng C, Ficarra V, Murai M, Oudard S, et al. Prognostic factors and predictive models in renal cell carcinoma: a contemporary review. Eur Urol. 2011;60(4):644–61.

    Article  Google Scholar 

  • Thorstenson A, Bergman M, Scherman-Plogell AH, Hosseinnia S, Ljungberg B, Adolfsson J, et al. Tumour characteristics and surgical treatment of renal cell carcinoma in Sweden 2005–2010: a population-based study from the national Swedish kidney cancer register. Scand J Urol. 2014;48(3):231–8.

    Article  Google Scholar 

  • Wah TM, Irving HC, Gregory W, Cartledge J, Joyce AD, Selby PJ. Radiofrequency ablation (RFA) of renal cell carcinoma (RCC): experience in 200 tumours. BJU Int. 2014;113(3):416–28.

    Article  Google Scholar 

  • Williamson TJ, Pearson JR, Ischia J, Bolton DM, Lawrentschuk N. Guideline of guidelines: follow-up after nephrectomy for renal cell carcinoma. BJU Int. 2016;117(4):555–62.

    Article  Google Scholar 

  • Zisman A, Pantuck AJ, Dorey F, Said JW, Shvarts O, Quintana D, et al. Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol. 2001;19(6):1649–57.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Surgical Oncology, Department of Urology, The Netherlands Cancer Institute, Amsterdam, The Netherlands

    Axel Bex

Authors
  1. Axel Bex
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Axel Bex .

Editor information

Editors and Affiliations

  1. Department of Urology, University Hospital Schleswig-Holstein Campus Lübeck, Lübeck, Germany

    Axel S. Merseburger

  2. Department of Urology, Caritas-St. Josef Medical Center, University of Regensburg, Regensburg, Germany

    Maximilian Burger

Section Editor information

  1. Klinik für Urologie, Lübeck, Germany

    Mario W. Kramer

  2. Department of Urology, University Hospital Schleswig-Holstein, Lübeck, Germany

    Axel S. Merseburger

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this entry

Check for updates. Verify currency and authenticity via CrossMark

Cite this entry

Bex, A. (2019). Advisable Follow-Up for Kidney Tumors. In: Merseburger, A., Burger, M. (eds) Urologic Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-42623-5_66

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-42623-5_66

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-42622-8

  • Online ISBN: 978-3-319-42623-5

  • eBook Packages: MedicineReference Module Medicine

Publish with us

Policies and ethics

Search

Navigation